Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

Clinical trial NCT06296056 · COMPLETED

Trial details

NCT number: NCT06296056
Sponsor: Seoul Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Metastatic

Start date: 2024-08-01
Primary completion: 2025-05-28
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.